Lancashire and South Cumbria
Formulary
Formulary
9 Nutrition and blood
09-02-01-01 Potassium removal
| Calcium polystyrene sulfonate Calcium Resonium® |
|
Formulary
|
Powder for oral or rectal suspension 99.934% w/w calcium polystyrene sulfonate |
|
| Patiromer calcium |
|
Formulary
|
Oral powder sachets 8.4g, 16.8g |
 NICE TA623: Patiromer for treating hyperkalaemia |
|
| Sodium zirconium cyclosilicate |
|
Formulary
|
Oral powder sachets 5g, 10g |
|
NICE TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia |
|
|
Links
- CAS: UPDATE: Discontinuation of Kay-Cee-L (potassium chloride 375mg/ml) (potassium chloride 5mmol/5ml) syrup
LSCMMG: Bariatric surgery guidelines for prescribing of vitamins and nutritional supplements: Position Statement- LSCMMG: Gluten-Free food products: Position Statement
- LSCMMG: Oral Nutritional Supplements in Primary Care
- LSCMMG: PKU - Prescribing of Multivitamins & Phenylalanine-free amino acid substitutes for adults and children
- NICE CG32: Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition
- NICE NG20: Coeliac disease: recognition, assessment and management
- NICE NG203: Chronic kidney disease: assessment and management
- NICE TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia
- NICE TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia
- NICE TA623: Patiromer for treating hyperkalaemia
- NICE TA623: Patiromer for treating hyperkalaemia